Lifestyle, Gut Microbiota and Health

A special issue of Microorganisms (ISSN 2076-2607). This special issue belongs to the section "Gut Microbiota".

Deadline for manuscript submissions: closed (31 May 2022) | Viewed by 33074

Special Issue Editors


E-Mail Website
Guest Editor
1. Nutrição e Metabolismo, Faculdade de Ciências Médicas/NOVA Medical School, Universidade NOVA de Lisboa, Lisboa 1169-056, Portugal
2. CINTESIS-Center for Health Technology Services Research, Faculdade de Ciências Médicas/NOVA Medical School, Universidade NOVA de Lisboa, Lisboa 1169-056, Portugal
Interests: gut microbiota; gut microbiome; diet; Mediterranean diet; functional foods; polyphenols obesity; diabetes; high-fat diet induced obesity; clinical trials; fecal microbiota transplant (FMT)

E-Mail Website
Guest Editor
1. NOVA Medical School Research, NOVA University of Lisbon, 1150-082 Lisbon, Portugal
2. Atlantic Technical University (UTA), Mindelo, São Vicente, CP 2110, Cabo Verde
Interests: gut microbiota; gut microbiome; iron metabolism; heme biology; inflammation; infections and neurodegeneration
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

The gut microbiome has opened a new horizon in nutrition and biomedical research by being implicated in metabolic diseases such as obesity, diabetes, and hypertension, among others. These diseases are also influenced by lifestyle factors such as dietary habits and exercise, which in turn can modify the composition of the gut microbiome. Thus, the gut microbiome can be considered an intermediary of the effects of diet and exercise on metabolic health assuming a special relevance in the prevention, treatment, and monitoring of these diseases.   

Diet is one of the most important factors that can modulate the gut microbiome and rapidly induce alterations in its composition. Some dietary components such as fiber and phytochemicals, as well as fermented foods (yogurt, kefir, wine, beer, etc.), may stimulate the growth or contain microorganisms that confer health benefits to the host. On the other hand, diet is also a source of exposure to environmental contaminants where the activity of endocrine disruptors may be mediated by gut microbiota modulation.

Recently, physical activity and exercise have been shown to beneficially modulate gut microbiota composition, increasing the relevance of these lifestyle factors in health.

The aim of this Special Issue is to gather more information on how our lifestyle including diet and exercise affect the gut microbiome and how this is associated with health. Therefore, I enthusiastically invite researchers to submit their research or review articles on this topic.

Dr. Cláudia Marques
Dr. Raffaella Gozzelino
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • lifestyle
  • diet
  • Mediterranean diet
  • physical activity
  • exercise
  • polyphenols
  • prebiotics
  • gut microbiota
  • gut microbiome

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (8 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review

20 pages, 5079 KiB  
Article
A Synthetic Formula Amino Acid Diet Leads to Microbiome Dysbiosis, Reduced Colon Length, Inflammation, and Altered Locomotor Activity in C57BL/6J Mice
by Viviana J. Mancilla, Paige N. Braden-Kuhle, Kelly N. Brice, Allison E. Mann, Megan T. Williams, Yan Zhang, Michael J. Chumley, Robert C. Barber, Sabrina N. White, Gary W. Boehm and Michael S. Allen
Microorganisms 2023, 11(11), 2694; https://doi.org/10.3390/microorganisms11112694 - 3 Nov 2023
Viewed by 1579
Abstract
The effects of synthetic, free-amino acid diets, similar to those prescribed as supplements for (phenylketonuria) PKU patients, on gut microbiota and overall health are not well understood. In the current, multidisciplinary study, we examined the effects of a synthetically-derived, low-fiber, amino acid diet [...] Read more.
The effects of synthetic, free-amino acid diets, similar to those prescribed as supplements for (phenylketonuria) PKU patients, on gut microbiota and overall health are not well understood. In the current, multidisciplinary study, we examined the effects of a synthetically-derived, low-fiber, amino acid diet on behavior, cognition, gut microbiome composition, and inflammatory markers. A cohort of 20 male C57BL/6J mice were randomly assigned to either a standard or synthetic diet (n = 10) at post-natal day 21 and maintained for 13 weeks. Sequencing of the 16S rRNA gene from fecal samples revealed decreased bacterial diversity, increased abundance of bacteria associated with disease, such as Prevotella, and a downward shift in gut microbiota associated with fermentation pathways in the synthetic diet group. Furthermore, there were decreased levels of short chain fatty acids and shortening of the colon in mice consuming the synthetic diet. Finally, we measured TNF-α, IL-6, and IL-10 in serum, the hippocampus, and colon, and found that the synthetic diet significantly increased IL-6 production in the hippocampus. These results demonstrate the importance of a multidisciplinary approach to future diet and microbiome studies, as diet not only impacts the gut microbiome composition but potentially systemic health as well. Full article
(This article belongs to the Special Issue Lifestyle, Gut Microbiota and Health)
Show Figures

Figure 1

23 pages, 6096 KiB  
Article
Gut Microbiome and Lipidome Signatures in Irritable Bowel Syndrome Patients from a Low-Income, Food-Desert Area: A Pilot Study
by Nikita Paripati, Lauren Nesi, John D. Sterrett, Lamya’a M. Dawud, Lyanna R. Kessler, Christopher A. Lowry, Lark J. Perez, Joshua DeSipio and Sangita Phadtare
Microorganisms 2023, 11(10), 2503; https://doi.org/10.3390/microorganisms11102503 - 6 Oct 2023
Cited by 1 | Viewed by 1916
Abstract
Irritable bowel syndrome (IBS) is a common gastroenterological disorder with triggers such as fructose. We showed that our IBS patients suffering from socioeconomic challenges have a significantly high consumption of high-fructose corn syrup (HFCS). Here, we characterize gut microbial dysbiosis and fatty acid [...] Read more.
Irritable bowel syndrome (IBS) is a common gastroenterological disorder with triggers such as fructose. We showed that our IBS patients suffering from socioeconomic challenges have a significantly high consumption of high-fructose corn syrup (HFCS). Here, we characterize gut microbial dysbiosis and fatty acid changes, with respect to IBS, HFCS consumption, and socioeconomic factors. Fecal samples from IBS patients and healthy controls were subjected to microbiome and lipidome analyses. We assessed phylogenetic diversity and community composition of the microbiomes, and used linear discriminant analysis effect size (LEfSe), analysis of compositions of microbiomes (ANCOM) on highly co-occurring subcommunities (modules), least absolute shrinkage and selection operator (LASSO) on phylogenetic isometric log-ratio transformed (PhILR) taxon abundances to identify differentially abundant taxa. Based on a Procrustes randomization test, the microbiome and lipidome datasets correlated significantly (p = 0.002). Alpha diversity correlated with economic factors (p < 0.001). Multiple subsets of the phylogenetic tree were associated with HFCS consumption (p < 0.001). In IBS patients, relative abundances of potentially beneficial bacteria such as Monoglobaceae, Lachnospiraceae, and Ruminococcaceae were lower (p = 0.007), and Eisenbergiella, associated with inflammatory disorders, was higher. In IBS patients, certain saturated fatty acids were higher and unsaturated fatty acids were lower (p < 0.05). Our study aims first to underscore the influence of HFCS consumption and socioeconomic factors on IBS pathophysiology, and provides new insights that inform patient care. Full article
(This article belongs to the Special Issue Lifestyle, Gut Microbiota and Health)
Show Figures

Figure 1

19 pages, 2548 KiB  
Article
Gut Dysbiosis: A Target for Protective Interventions against Parkinson’s Disease
by Illyane S. Lima, Ana C. Pêgo, Ana C. Martins, Ana R. Prada, João Tomás Barros, Gracelino Martins and Raffaella Gozzelino
Microorganisms 2023, 11(4), 880; https://doi.org/10.3390/microorganisms11040880 - 29 Mar 2023
Cited by 7 | Viewed by 2857
Abstract
Sub-chronic inflammation, caused by age-related dysbiosis, primes the brain to neuroinflammation and neurodegenerative diseases. Evidence revealed that Parkinson’s disease (PD) might originate in the gut, demonstrating gastro-intestinal disturbances, as reported by PD patients long before developing motor symptoms. In this study, we conducted [...] Read more.
Sub-chronic inflammation, caused by age-related dysbiosis, primes the brain to neuroinflammation and neurodegenerative diseases. Evidence revealed that Parkinson’s disease (PD) might originate in the gut, demonstrating gastro-intestinal disturbances, as reported by PD patients long before developing motor symptoms. In this study, we conducted comparative analyses in relatively young and old mice maintained in conventional or gnotobiotic conditions. We aimed to confirm that the effects induced by age-related dysbiosis, rather than aging itself, sensitize to PD onset. This hypothesis was confirmed in germ-free (GF) mice, which proved resistant to the pharmacological induction of PD, regardless of their age. Contrary to conventional animals, old GF mice did not develop an inflammatory phenotype or an accumulation of iron in the brain, two catalysts sensitizing to disease onset. The resistance of GF mice to PD is reverted when colonized with stool collected from conventional old animals, but not if receiving bacterial content from young mice. Hence, changes in gut microbiota composition are a risk factor for PD development and can be targeted preventively by iron chelators, shown to protect the brain from pro-inflammatory intestinal priming that sensitizes to neuroinflammation and the development of severe PD. Full article
(This article belongs to the Special Issue Lifestyle, Gut Microbiota and Health)
Show Figures

Figure 1

14 pages, 1922 KiB  
Article
Dietary Microencapsulated Blend of Organic Acids and Plant Essential Oils Affects Intestinal Morphology and Microbiome of Rainbow Trout (Oncorhynchus mykiss)
by David Huyben, Marcia Chiasson, John S. Lumsden, Phuc H. Pham and Mohiuddin A. Kabir Chowdhury
Microorganisms 2021, 9(10), 2063; https://doi.org/10.3390/microorganisms9102063 - 30 Sep 2021
Cited by 19 | Viewed by 3384
Abstract
A study was conducted on 500 juvenile rainbow trout (122 ± 4 g) fed either a control diet or a treatment diet containing 300 mg/kg of a microencapsulated blend of organic acids and essential oils to elucidate effects on intestinal morphology and microbiome. [...] Read more.
A study was conducted on 500 juvenile rainbow trout (122 ± 4 g) fed either a control diet or a treatment diet containing 300 mg/kg of a microencapsulated blend of organic acids and essential oils to elucidate effects on intestinal morphology and microbiome. Proximal intestinal villi length was significantly increased in fish fed the treatment diet. Despite no differences in gut inflammation scores, edema, lamina propria inflammation and apoptosis were completely absent in the distal intestine of fish fed the treatment diet. Next-generation sequencing of the 16S rDNA showed no differences in alpha and beta diversity, and gut bacteria were mainly composed of Firmicutes, Bacteroidetes and Proteobacteria. On the genus level, LefSe analysis of indicator OTUs showed Bacteroides, Sporosarcina, Veillonella, Aeromonas and Acinetobacter were associated with the control diet whereas Streptococcus, Fusobacterium and Escherichia were associated with the treatment diet. Aeromonas hydrophila and Acinetobacter spp. are opportunistic pathogens and several strains have been found to be resistant to antibiotics. The increase in villi length and reduction of specific pathogens indicates that feeding a microencapsulated blend of organic acids and essential oils improves gut health and may serve as a part of an effective strategy to reduce antibiotic use in aquaculture. Full article
(This article belongs to the Special Issue Lifestyle, Gut Microbiota and Health)
Show Figures

Figure 1

15 pages, 2485 KiB  
Article
Degradation Products of Complex Arabinoxylans by Bacteroides intestinalis Enhance the Host Immune Response
by Taro Yasuma, Masaaki Toda, Ahmed M. Abdel-Hamid, Corina D’Alessandro-Gabazza, Tetsu Kobayashi, Kota Nishihama, Valeria Fridman D’Alessandro, Gabriel V. Pereira, Roderick I. Mackie, Esteban C. Gabazza and Isaac Cann
Microorganisms 2021, 9(6), 1126; https://doi.org/10.3390/microorganisms9061126 - 22 May 2021
Cited by 23 | Viewed by 3656
Abstract
Bacteroides spp. of the human colonic microbiome degrade complex arabinoxylans from dietary fiber and release ferulic acid. Several studies have demonstrated the beneficial effects of ferulic acid. Here, we hypothesized that ferulic acid or the ferulic acid-rich culture supernatant of Bacteroides intestinalis, [...] Read more.
Bacteroides spp. of the human colonic microbiome degrade complex arabinoxylans from dietary fiber and release ferulic acid. Several studies have demonstrated the beneficial effects of ferulic acid. Here, we hypothesized that ferulic acid or the ferulic acid-rich culture supernatant of Bacteroides intestinalis, cultured in the presence of complex arabinoxylans, enhances the immune response. Ferulic acid and the culture supernatant of bacteria cultured in the presence of insoluble arabinoxylans significantly decreased the expression of tumor necrosis factor-α and increased the expression of interleukin-10 and transforming growth factor β1 from activated dendritic cells compared to controls. The number of granulocytes in mesenteric lymph nodes, the number of spleen monocytes/granulocytes, and interleukin-2 and interleukin-12 plasma levels were significantly increased in mice treated with ferulic acid or the culture supernatant of bacteria cultured with insoluble arabinoxylans. Ferulic acid or the culture supernatant of bacteria cultured with insoluble arabinoxylans increased the expression of interleukin-12, interferon-α, and interferon-β in intestinal epithelial cell lines. This study shows that ferulic acid or the ferulic acid-rich culture supernatant of the colonic bacterium Bacteroides intestinalis, cultured with insoluble arabinoxylans, exerts anti-inflammatory activity in dendritic cells under inflammatory conditions and enhances the Th1-type immune response under physiological conditions in mice. Full article
(This article belongs to the Special Issue Lifestyle, Gut Microbiota and Health)
Show Figures

Figure 1

19 pages, 5225 KiB  
Article
Gut Microbiome of Indonesian Adults Associated with Obesity and Type 2 Diabetes: A Cross-Sectional Study in an Asian City, Yogyakarta
by Phatthanaphong Therdtatha, Yayi Song, Masaru Tanaka, Mariyatun Mariyatun, Maisaroh Almunifah, Nancy Eka Putri Manurung, Siska Indriarsih, Yi Lu, Koji Nagata, Katsuya Fukami, Tetsuo Ikeda, Yuan-Kun Lee, Endang Sutriswati Rahayu and Jiro Nakayama
Microorganisms 2021, 9(5), 897; https://doi.org/10.3390/microorganisms9050897 - 22 Apr 2021
Cited by 25 | Viewed by 5987
Abstract
Indonesia is a developing country facing the national problem of the growing obesity and diabetes in its population due to recent drastic dietary and lifestyle changes. To understand the link between the gut microbiome, diet, and health of Indonesian people, fecal microbiomes and [...] Read more.
Indonesia is a developing country facing the national problem of the growing obesity and diabetes in its population due to recent drastic dietary and lifestyle changes. To understand the link between the gut microbiome, diet, and health of Indonesian people, fecal microbiomes and metabolomes of 75 Indonesian adults in Yogyakarta City, including obese people (n = 21), type 2 diabetes (T2D) patients (n = 25), and the controls (n = 29) were characterized together with their dietary and medical records. Variations of microbiomes showed a triangular distribution in the principal component analysis, driven by three dominant bacterial genera, namely Bacteroides, Prevotella, and Romboutsia. The Romboutsia-driven microbiome, characterized by low bacterial diversity and high primary bile acids, was associated with fat-driven obesity. The Bacteroides-driven microbiome, which counteracted Prevotella but was associated with Ruminococcaceae concomitantly increased with high-carbohydrate diets, showed positive correlation with T2D indices but negative correlation with body mass index. Notably, Bacteroides fragilis was increased in T2D patients with a decrease in fecal conjugated bile acids, particularly tauroursodeoxycholic acid (TUDCA), a farnesoid X receptor (FXR) antagonist with anti-diabetic activity, while these features disappeared in patients administered metformin. These results indicate that the gut microbiome status of Indonesian adults is differently associated with obesity and T2D under their varied dietary habits. Full article
(This article belongs to the Special Issue Lifestyle, Gut Microbiota and Health)
Show Figures

Figure 1

Review

Jump to: Research

15 pages, 1446 KiB  
Review
Intestinal Alkaline Phosphatase: A Review of This Enzyme Role in the Intestinal Barrier Function
by Gilberto Maia Santos, Shámila Ismael, Juliana Morais, João R. Araújo, Ana Faria, Conceição Calhau and Cláudia Marques
Microorganisms 2022, 10(4), 746; https://doi.org/10.3390/microorganisms10040746 - 30 Mar 2022
Cited by 28 | Viewed by 8252
Abstract
Intestinal alkaline phosphatase (IALP) has recently assumed a special relevance, being the subject of study in the prevention and treatment of certain diseases related to leaky gut. This brush border enzyme (ecto-enzyme) plays an important role in the maintenance of intestinal microbial homeostasis [...] Read more.
Intestinal alkaline phosphatase (IALP) has recently assumed a special relevance, being the subject of study in the prevention and treatment of certain diseases related to leaky gut. This brush border enzyme (ecto-enzyme) plays an important role in the maintenance of intestinal microbial homeostasis and intestinal barrier function through its ability to dephosphorylate lipopolysaccharide (LPS). This review addresses how IALP and intestinal barrier dysfunction may be implicated in the pathophysiology of specific diseases such as inflammatory bowel disease, necrotizing enterocolitis, and metabolic syndrome. The use of IALP as a possible biomarker to assess intestinal barrier function and strategies to modulate IALP activity are also discussed. Full article
(This article belongs to the Special Issue Lifestyle, Gut Microbiota and Health)
Show Figures

Graphical abstract

22 pages, 356 KiB  
Review
Biliary Diseases from the Microbiome Perspective: How Microorganisms Could Change the Approach to Benign and Malignant Diseases
by Cecilia Binda, Giulia Gibiino, Chiara Coluccio, Monica Sbrancia, Elton Dajti, Emanuele Sinagra, Gabriele Capurso, Vittorio Sambri, Alessandro Cucchetti, Giorgio Ercolani and Carlo Fabbri
Microorganisms 2022, 10(2), 312; https://doi.org/10.3390/microorganisms10020312 - 28 Jan 2022
Cited by 21 | Viewed by 4346
Abstract
Recent evidence regarding microbiota is modifying the cornerstones on pathogenesis and the approaches to several gastrointestinal diseases, including biliary diseases. The burden of biliary diseases, indeed, is progressively increasing, considering that gallstone disease affects up to 20% of the European population. At the [...] Read more.
Recent evidence regarding microbiota is modifying the cornerstones on pathogenesis and the approaches to several gastrointestinal diseases, including biliary diseases. The burden of biliary diseases, indeed, is progressively increasing, considering that gallstone disease affects up to 20% of the European population. At the same time, neoplasms of the biliary system have an increasing incidence and poor prognosis. Framing the specific state of biliary eubiosis or dysbiosis is made difficult by the use of heterogeneous techniques and the sometimes unwarranted invasive sampling in healthy subjects. The influence of the microbial balance on the health status of the biliary tract could also account for some of the complications surrounding the post-liver-transplant phase. The aim of this extensive narrative review is to summarize the current evidence on this topic, to highlight gaps in the available evidence in order to guide further clinical research in these settings, and, eventually, to provide new tools to treat biliary lithiasis, biliopancreatic cancers, and even cholestatic disease. Full article
(This article belongs to the Special Issue Lifestyle, Gut Microbiota and Health)
Back to TopTop